-
Posted by
Two Blokes Jun 30 -
Filed in
Stock
-
5 views
ASL Strategic Value Fund plans to push shareholders of drugmaker Avadel Pharmaceuticals to vote to remove the company's board, citing mismanagement in the launch of its flagship sleep disorder drug, the Wall Street Journal reported on Sunday.
